AOD 9604 5mg

for: Anti-Obesity Drug-9604, Fat Burning; Weight Loss; Heart Disease; Metabolic.

AOD9604 (Advanced Obesity Drug) is a synthetic analog of the C-terminal fragment of Human Growth Hormone (hGH), specifically encompassing amino acids 177–191. Unlike the full-length hormone, this peptide is engineered to isolate the metabolic benefits of hGH, specifically its ability to stimulate fat metabolism without inducing the systemic growth effects or insulin resistance associated with the parent molecule. Dragon Pharma provides AOD9604 at a purity of 99%+, serving as a vital tool for investigators exploring adipocyte differentiation, lipid signaling, and metabolic homeostasis.

Product Overview

• Product Name: AOD9604 (Advanced Obesity Drug)
• Quantity: 6mg per vial
• Purity: 99%+ (USA Made)
• Form: Lyophilized (freeze-dried) powder for maximum stability.
• Price: $65.00 (with tiered discounts for bulk orders).

Biochemical Characteristics

• Molecular Formula: C78H123N23O23S2
• Molecular Weight: 1815.1 g/mol
• Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
• Purity: >99% (HPLC/MS Verified)
• CAS Number: 221231-10-3
• Manufacturer: Dragon Pharma
• Form: Lyophilized white powder

Pathway & Mechanistic Context

AOD9604 functions through a highly specific mechanism that distinguishes it from traditional growth factors. By isolating the 177–191 fragment of the hGH molecule, researchers can probe the lipolytic pathways of growth hormone without activating the IGF-1 (Insulin-like Growth Factor 1) receptor.

The mechanism of action is hypothesized to involve:

• Beta-3 Adrenergic Receptor Interaction: Studies suggest that AOD9604 may interact with the $\beta$3-adrenergic receptors in adipose tissue. This interaction facilitates the stimulation of lipolysis (the breakdown of stored triglycerides) and the inhibition of lipogenesis (the formation of new fat cells).
• AMPK Activation: Like other metabolic regulators, AOD9604 is believed to influence the AMP-activated protein kinase (AMPK) pathway. By modulating this "metabolic switch," the peptide promotes a state of energy expenditure within the cell.
• Selective Lipolytic Action: Unlike full-length hGH, AOD9604 does not stimulate the hGH receptor associated with growth. This allows researchers to study fat metabolism pathways in isolation, avoiding variables such as changes in blood glucose levels or unwanted cellular proliferation.

Primary Research Applications

AOD9604 6mg is utilized in a variety of preclinical and in-vitro models, including:

• Adiposity and Lipid Signaling: Investigating the biochemical signals that govern fat cell maturation and storage.
• Metabolic Syndrome Models: Exploring how specific fragments of hGH influence lipid profiles and energy dynamics without affecting insulin sensitivity.
• Bone and Cartilage Repair: Recent research has expanded to include the study of AOD9604 in regenerative medicine, specifically its potential to influence chondrocyte proliferation and the repair of connective tissues.
• Exercise Mimicry: Analyzing how the peptide replicates the fat-mobilizing effects of endogenous growth hormone pulses normally triggered by physical exertion.

Form & Analytical Testing

Dragon Pharma maintains strict quality control protocols to ensure the scientific validity of your research results.

• Lyophilization: Every vial of AOD9604 is produced using the lyophilization (freeze-drying) process. This dehydration technique preserves the crystalline structure of the peptide, ensuring it remains 100% stable during shipping and long-term storage.
• Purity Verification: Product identity and purity are confirmed using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). These tests verify that the peptide matches the intended molecular sequence and is free from synthesis byproducts or residual contaminants.
• Solubility: Formulated as a highly soluble lyophilized powder, it is designed for ease of reconstitution with bacteriostatic water or sterile saline for precise laboratory application.

Dragon Pharma Research Disclaimer

AOD9604 6mg is intended for LABORATORY RESEARCH USE ONLY. This compound is a research chemical and is not intended for human or animal consumption. It is not a drug, food additive, or cosmetic. Under no circumstances should this product be used for therapeutic, medical, or recreational purposes. All research must be conducted by qualified professionals in a controlled, supervised environment. Dragon Pharma assumes no liability for damages resulting from misuse or unauthorized application of this compound.

Product Usage Disclaimer: This product is intended for laboratory and in-vitro research use only. It is not approved for human or veterinary application. Must be handled by qualified professionals. Not for drug, food, or cosmetic purposes. Misuse or misbranding is strictly prohibited.